1. Generics Bulletin
  2. >>Policy & Regulation

Generic Price Fixing Probe: First Charges Unsealed, More May Come Before Inauguration Day

 
• By Brenda Sandburg

Heritage Pharmaceuticals’ former CEO and former president charged by US DOJ with conspiracy to fix prices and allocate customers for doxycycline and glyburide; Heritage alleges they embezzled intellectual property.

United States Department of Justice headquarter building in Washington D.C.

The Department of Justice has filed the first charges in its two-year antitrust investigation of the generic drug industry, charging two former executives at Heritage Pharmaceuticals Inc. with conspiracy to fix prices and allocate customers for the antibiotic doxycycline and the diabetes drug glyburide.

The felony charges against former CEO Jeffrey Glazer and former president Jason Malek were unsealed Dec. 14 in the US District Court for the Eastern District of Pennsylvania. The charges do not identify their former company but refer to it as Company A

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Generics Bulletin

Apotex Extends Formosa Ophthalmic Alliance Into Mexico

 
• By Dave Wallace

Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.

Fresenius Kabi Lauds Tocilizumab Momentum As ‘Intense’ Transfer To mAbxience Continues

 
• By Dean Rudge

Fresenius Kabi continued to reap the rewards of its fledgling commercial Biopharma business in the first quarter, as the firm eyes further growth for its tocilizumab biosimilar in the US and Europe in the second half of 2025.

US FDA Expands Surprise Foreign Inspections

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.